sulfosuccinimidyl 2-(4-azidosalicylamido)ethyl-1,3'-dithiopropionate: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 3035796 |
| SCHEMBL ID | 13857015 |
| MeSH ID | M0136591 |
| Synonym |
|---|
| sasdp |
| 3-pyrrolidinesulfonic acid, 1-(3-((2-((4-azido-2-hydroxybenzoyl)amino)ethyl)dithio)-1-oxopropoxy)-2,5-dioxo- |
| sulfosuccinimidyl 2-(4-azidosalicylamido)ethyl-1,3'-dithiopropionate |
| 98897-08-6 |
| SCHEMBL13857015 |
| DTXSID40913009 |
| 4-azido-n-[2-({3-[(2,5-dioxo-3-sulfopyrrolidin-1-yl)oxy]-3-oxopropyl}disulfanyl)ethyl]-2-hydroxybenzene-1-carboximidic acid |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 6 (42.86) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.44) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 15 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||